Ratings from B. Riley Securities for Mirati Therapeutics, Inc. [MRTX]

▲

8/9/23	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics B. Riley Securities
$45
10/28/22	Initiated	Neutral	X
MRTX Mirati Therapeutics B. Riley Securities
$72

MRTX Mirati Therapeutics, Inc.

Analyst Firm:	B. Riley Securities
Tickers:	MRTX